Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options
Christoph Grander, Felix Grabherr, Herbert Tilg
Cardiovascular Research (2023) Vol. 119, Iss. 9, pp. 1787-1798
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond
Allison Soto, Colby Spongberg, Alessandro Martinino, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 397-397
Open Access | Times Cited: 20
Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999–2018
Yusha Zhang, Fengjiao Wang, Jianjun Tang, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Cardiac metabolic index as a predictor of new-onset diabetes in non-alcoholic fatty liver disease patients: a longitudinal cohort analysis
Shanbing Hou, Yuqing Wang, Zixuan Wei, et al.
BMC Endocrine Disorders (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease
Saira Rafaqat, Sanja Gluščević, Filiz Mercantepe, et al.
Metabolites (2024) Vol. 14, Iss. 3, pp. 153-153
Open Access | Times Cited: 11
Thyroid function, adipokines and mitokines in metabolic dysfunction‐associated steatohepatitis: A multi‐centre biopsy‐based observational study
Matina Kouvari, Laura Valenzuela‐Vallejo, Evangelos Axarloglou, et al.
Liver International (2024) Vol. 44, Iss. 3, pp. 848-864
Open Access | Times Cited: 7
Lipid Nanoparticle‐Mediated Delivery of CRISPR‐Cas9 Against Rubicon Ameliorates NAFLD by Modulating CD36 Along with Glycerophospholipid Metabolism
Yu Bai, Yanyang Nan, Tao Wu, et al.
Advanced Science (2024) Vol. 11, Iss. 31
Open Access | Times Cited: 6
Liver fibrosis: More than meets the eye
Amedeo Lonardo
Annals of Hepatology (2024) Vol. 29, Iss. 4, pp. 101479-101479
Open Access | Times Cited: 5
Increased MASH-associated liver cancer in younger demographics
Pojsakorn Danpanichkul, Yanfang Pang, Kanokphong Suparan, et al.
Hepatology Communications (2025) Vol. 9, Iss. 1
Open Access
FucoVital® inhibits fatty acid accumulation in liver cells in vitro and reduces triglycerides levels in patients with NAFLD
Anton Bermont, Daniel L. Cohen, Vered Richter, et al.
PharmaNutrition (2025) Vol. 31, pp. 100429-100429
Closed Access
The Triad of Risk: Linking MASLD, Cardiovascular Disease and Type 2 Diabetes; From Pathophysiology to Treatment
Eleni Michalopoulou, J Thymis, Stamatios Lampsas, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 428-428
Open Access
Olivetol’s Effects on Metabolic State and Gut Microbiota Functionality in Mouse Models of Alimentary Obesity, Diabetes Mellitus Type 1 and 2, and Hypercholesterolemia
Anastasia A. Zabolotneva, K. E. Popruga, В. В. Макаров, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 183-183
Open Access
Association between neutrophil-albumin ratio and ultrasound-defined metabolic dysfunction-associated fatty liver disease in U.S. adults: evidence from NHANES 2017–2018
M R He, Xin-jie Du, Yi-ming Liu
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Camellia seed oil exerts a more gradual influence on the progression of high-fat diet induced NAFLD mice compared to corn oil: Insights from gut microbiota and metabolomics
Yuan Zhou, Zichuan Wang, Jianbiao Li, et al.
Food Bioscience (2025), pp. 105960-105960
Closed Access
Nonalcoholic fatty liver disease and chronic kidney disease: random connections or two manifestations of metabolic syndrome?
Н. С. Карпунина, О. В. Хлынова
Experimental and Clinical Gastroenterology (2025), Iss. 8, pp. 123-130
Closed Access
Effects of time restricted feeding combined with Lacto Ovo vegetarian diet on metabolic associated fatty liver disease management: a randomized clinical trial
Mahshad Shafiee, Amir Sadeghi, Fariba Taleghani, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Xiao Ma, Tengda Huang, Xi Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
The efficacy of sodium-glucose transporter 2 inhibitors in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis
Hongsheng Li, Yanli Hou, Xin Wang, et al.
Pharmacological Research (2025) Vol. 213, pp. 107647-107647
Open Access
Association between prognostic nutritional index and all-cause mortality and cardiovascular disease mortality in American adults with non-alcoholic fatty liver disease
Yu‐Qing Lei, Shaohong Tao, Yubo Yang, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
LIMA1 O‐GlcNAcylation Promotes Hepatic Lipid Deposition through Inducing β‐catenin‐Regulated FASn Expression in Metabolic Dysfunction‐Associated Steatotic Liver Disease
Fuji Yang, Yifei Chen, Guojun Zheng, et al.
Advanced Science (2025)
Open Access
Potential predictive role of Non-HDL to HDL Cholesterol Ratio (NHHR) in MASLD: focus on obese and type 2 diabetic populations
Xiaoman Ma, Yu-Miao Guo, Shuyi Jiang, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Aurantio‐Obtusin Regulates Gut Microbiota and Serum Metabolism to Alleviate High‐Fat Diet‐Induced Obesity‐Associated Non‐Alcoholic Fatty Liver Disease in Mice
Zhen-Lin Li, Jin Yao, Hua-Shan Zhao, et al.
Phytotherapy Research (2025)
Closed Access
Different formulations of semaglutide and oxidative stress in subjects with type 2 diabetes and MASLD: an open-label, real-life study
Giovanni Petralli, A. Zoppo, Chiara Rovera, et al.
Acta Diabetologica (2025)
Closed Access
Andrographolide Inhibits the NF-κB Signaling Pathway and Alleviates High-Fat Diet-Induced Hepatic Inflammation in a Mouse Model of Nonalcoholic Fatty Liver Disease
Weiwen Hu, Yilin Chen, Wenhong Tan, et al.
Natural Product Communications (2025) Vol. 20, Iss. 2
Open Access
Non alkolik yağlı karaciğer hastalığı ile kafein alımı arasındaki ilişki
İzel Akkaya, İlknur Gökçe Yıldırım
Sağlık Profesyonelleri Araştırma Dergisi (2025) Vol. 7, Iss. 1, pp. 47-56
Closed Access
Traditional Mongolian Medicine Qiqirigan-8 alleviates non-alcoholic fatty liver disease via restoring gut microbiota and metabolism
Yang Dandan, Wuyunsiqin, YanNiu, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Page 1 - Next Page

Scroll to top